This HTML5 document contains 181 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n12http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n8https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q53208361
rdf:type
wikibase:Item
schema:description
vitskapeleg artikkel tieteellinen artikkeli vědecký článek articol științific 2016年学术文章 artikulong pang-agham 2016年学术文章 vitenskapelig artikkel article scientifique scientific article published on 16 January 2016 artigo científico artykuł naukowy 2016年の論文 επιστημονικό άρθρο vetenskaplig artikel 2016年學術文章 articolo scientifico научная статья 2016년 논문 wetenschappelijk artikel videnskabelig artikel article scientific מאמר מדעי 2016年学术文章 2016年學術文章 2016年學術文章 article científic ১৬ জানুয়ারি ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ სამეცნიერო სტატია บทความทางวิทยาศาสตร์ teaduslik artikkel мақолаи илмӣ tudományos cikk artikel ilmiah artigo científico 2016年学术文章 2016 nî lūn-bûn artículo científico publicado en 2016 2016年学术文章 artikull shkencor scientific article published on 16 January 2016 наукова стаття, опублікована в січні 2016 научни чланак scientific article published on 16 January 2016 scienca artikolo artigo científico 2016年學術文章 naučni članak مقالة علمية نشرت في 16 يناير 2016 научни чланак bài báo khoa học bilimsel makale 2016年學術文章 artículu científicu vedecký článok wissenschaftlicher Artikel научна статия 2016年学术文章
p:P577
wds:Q53208361-15354D73-49DF-4081-9E27-35FA8A797163
wdt:P577
2016-01-16T00:00:00Z
p:P2888
wds:Q53208361-8C958F81-FCAF-48E5-BC81-52F23A5525AF
wdt:P2888
n8:s12035-015-9645-9
p:P2860
wds:Q53208361-867D96D5-8DE8-407A-B049-A89725DD4F09 wds:Q53208361-868C0875-C146-4420-B1F2-FE188F29E9F5 wds:Q53208361-8B054D51-6B06-410F-9F32-22982BA5F32A wds:Q53208361-8BE2F7A4-E9C2-4FCA-A7DC-3219C8F14685 wds:Q53208361-69944495-0E30-4CE2-A86F-9CCDFB167AE2 wds:Q53208361-806488E4-4140-4923-A25D-DC70ED80ABCE wds:Q53208361-9FEF64AC-A950-4B6F-9343-AB11A1470416 wds:Q53208361-A22CC80F-FBB4-4652-9150-6FBA328F9A0C wds:Q53208361-A6B640F9-2C27-4451-A508-EB981A746740 wds:Q53208361-AA1500E7-84A8-45AC-B138-76D16EDE7C16 wds:Q53208361-8DD738D5-C5D4-4E12-A936-E1BFF395039E wds:Q53208361-9698FE43-3BFB-46C6-BB73-4830CE1D4456 wds:Q53208361-98CD76AA-E19A-4476-9F69-39927FB7F0F2 wds:Q53208361-BBAAAD26-F569-45B1-BC72-606F41B0CEF6 wds:Q53208361-BC14E17F-4A29-45DA-A1BC-00FFE0023197 wds:Q53208361-BF30B09D-3A60-4129-80CB-FD883A6E0244 wds:Q53208361-C466D591-82F9-4ABB-ADD7-9101B76FA4CD wds:Q53208361-B4CB67AC-A697-4D17-8749-6FBFEDFA5E7C wds:Q53208361-B545137D-E1C8-4B70-B8D0-DB458701CD21 wds:Q53208361-E5F0765E-DC0C-4525-9146-46FF0FAFEEBD wds:Q53208361-E63F4462-971E-47A9-B0BF-F0F2EC3997DF wds:Q53208361-F032C3CA-2699-4B39-95CA-5711E558CECF wds:Q53208361-F28EDB8D-A47F-4F79-8EDD-6A5D02C16C2C wds:Q53208361-C936E09F-0709-406A-91B7-93F35B51D840 wds:Q53208361-D174BA0B-083E-4566-BCCE-547FAC14AA06 wds:Q53208361-FCB86D11-B6D8-4E66-A1ED-A763AC42AAAE wds:Q53208361-1F4E3968-7EC3-4725-8DC8-8CDB5DD10C0D wds:Q53208361-22469A59-7F86-459C-842A-59561C93DCB0 wds:Q53208361-232C0633-0BCD-42E0-BFFC-14900C96E3D2 wds:Q53208361-0312F9F1-6222-4A84-9BE4-01E58FA28B0B wds:Q53208361-37C40C04-93C4-4B44-801D-9493F21EDDE2 wds:Q53208361-3AED39CC-302C-4D86-A99F-4D1E3C551346 wds:Q53208361-2E17D8A6-31B7-456C-9561-F2D5D19399F2 wds:Q53208361-357594B0-EF12-41D1-9B46-83641FC233B5 wds:Q53208361-4DDBADE7-0DBD-4104-8BDD-DE33016B4022 wds:Q53208361-5B72D32D-5C85-41DF-B8DC-F211524D3162 wds:Q53208361-62239B10-081F-4D6C-B0D8-71DF7CA3EB57 wds:Q53208361-67A487E6-A33A-43A6-8595-86FFFEAAC5E0 wds:Q53208361-3FAAD905-FCC9-43F4-B8D5-68319153E0AB wds:Q53208361-4729D95C-AD40-4471-B094-B3EFAA074429 wds:Q53208361-4800A987-FE5A-4941-AD46-10B9DCD4918A wds:Q53208361-4D1B745C-4918-45D3-9CA4-05406C83448D
wdt:P2860
wd:Q38017493 wd:Q26800135 wd:Q37073400 wd:Q83366198 wd:Q85645722 wd:Q36287703 wd:Q36572543 wd:Q35132609 wd:Q28244314 wd:Q44543879 wd:Q45339312 wd:Q36630179 wd:Q26801787 wd:Q48115341 wd:Q39108752 wd:Q46566592 wd:Q42491492 wd:Q30422488 wd:Q42411644 wd:Q83418836 wd:Q41560950 wd:Q28593725 wd:Q28194382 wd:Q38203811 wd:Q37231373 wd:Q52583321 wd:Q37228797 wd:Q44470659 wd:Q30416178 wd:Q22306370 wd:Q48499616 wd:Q85735919 wd:Q39022668 wd:Q48852632 wd:Q42230502 wd:Q36572996 wd:Q69660651 wd:Q83332757 wd:Q37971931 wd:Q84508179 wd:Q58197645 wd:Q35811036
p:P2093
wds:Q53208361-B822FE4D-3D2B-4C8A-85F7-4D9F0E22DC3A wds:Q53208361-B33CFD39-C12A-4594-BF91-63CEC312BDA7 wds:Q53208361-2336AB39-BF00-4F9F-9961-B26CFB85994F wds:Q53208361-C8681AAF-FD47-4DAF-B4FA-CC956DCB37D0 wds:Q53208361-3776E10E-9DEC-49F1-86E1-578A0ACF4312
wdt:P2093
Chuan-Jie Wu Xuan Cheng Nan-Chang Xie Yun-Qing Ma Ya-Jun Lian
rdfs:label
Elevated Serum Levels of CXC Chemokine Ligand-12 Are Associated with Unfavorable Functional Outcome and Mortality at 6-Month Follow-up in Chinese Patients with Acute Ischemic Stroke. Elevated Serum Levels of CXC Chemokine Ligand-12 Are Associated with Unfavorable Functional Outcome and Mortality at 6-Month Follow-up in Chinese Patients with Acute Ischemic Stroke.
skos:prefLabel
Elevated Serum Levels of CXC Chemokine Ligand-12 Are Associated with Unfavorable Functional Outcome and Mortality at 6-Month Follow-up in Chinese Patients with Acute Ischemic Stroke. Elevated Serum Levels of CXC Chemokine Ligand-12 Are Associated with Unfavorable Functional Outcome and Mortality at 6-Month Follow-up in Chinese Patients with Acute Ischemic Stroke.
schema:name
Elevated Serum Levels of CXC Chemokine Ligand-12 Are Associated with Unfavorable Functional Outcome and Mortality at 6-Month Follow-up in Chinese Patients with Acute Ischemic Stroke. Elevated Serum Levels of CXC Chemokine Ligand-12 Are Associated with Unfavorable Functional Outcome and Mortality at 6-Month Follow-up in Chinese Patients with Acute Ischemic Stroke.
p:P1476
wds:Q53208361-0D06A12C-EDC6-429E-A515-35AE64A6C036
wdt:P1476
Elevated Serum Levels of CXC Chemokine Ligand-12 Are Associated with Unfavorable Functional Outcome and Mortality at 6-Month Follow-up in Chinese Patients with Acute Ischemic Stroke.
p:P304
wds:Q53208361-E41BCE45-7DC4-4923-B8E6-FB4AE821826F
wdt:P304
895-903
p:P31
wds:Q53208361-85DECA4A-784B-400C-B481-938F8F8FDAF7
wdt:P31
wd:Q13442814
p:P698
wds:Q53208361-251CF1CB-1B3F-4BE8-9284-4240555A1FEA
wdtn:P698
n13:26780459
wdt:P698
26780459
p:P1433
wds:Q53208361-80EB4227-CE37-418A-A64B-EAFE71810468
wdt:P1433
wd:Q15716645
p:P433
wds:Q53208361-FF7598BA-5969-4F1F-8EB7-3038D3B7E7EC
p:P478
wds:Q53208361-F4545751-55ED-4C68-9E00-2C8CAFCA27A3
wdt:P433
2
wdt:P478
54
p:P356
wds:Q53208361-360CC954-8732-4956-AF92-00C6480716C6
wdtn:P356
n12:S12035-015-9645-9
wdt:P356
10.1007/S12035-015-9645-9